• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

晚期糖基化终末产物的毒性(综述)

Toxicity of advanced glycation end products (Review).

作者信息

Kuzan Aleksandra

机构信息

Department of Medical Biochemistry, Faculty of Medicine, Wrocław Medical University, Wrocław 50-368, Poland.

出版信息

Biomed Rep. 2021 May;14(5):46. doi: 10.3892/br.2021.1422. Epub 2021 Mar 18.

DOI:10.3892/br.2021.1422
PMID:33786175
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC7995243/
Abstract

Advanced glycation end-products (AGEs) are proteins or lipids glycated nonenzymatically by glucose, or other reducing sugars and their derivatives, such as glyceraldehyde, glycolaldehyde, methyloglyoxal and acetaldehyde. There are three different means of AGE formation: i) Maillard reactions, the polyol pathway and lipid peroxidation. AGEs participate in the pathological mechanisms underlying the development of several diseases, such as diabetes and its complications, retinopathy or neuropathy, neurological disorders (for example, Parkinson's disease and Alzheimer's disease), atherosclerosis, hypertension and several types of cancer. AGE levels are increased in patients with hyperglycaemia, and is likely the result of the high concentration of glycation substrates circulating in the blood. The present review summarises the formation and nomenclature of advanced glycation end-products, with an emphasis on the role of AGEs in the development of diabetes, neurological disorders, as well as in cancer and other pathologies. A particular focus is placed on the functions of toxic AGEs. Additionally, studies which have shown the cytotoxicity of glycated albumin and other AGEs are also discussed. Finally, the diagnostic relevance of AGEs as well as for targeting in therapeutic strategies are highlighted.

摘要

晚期糖基化终末产物(AGEs)是由葡萄糖或其他还原糖及其衍生物(如甘油醛、乙醇醛、甲基乙二醛和乙醛)非酶糖基化的蛋白质或脂质。AGEs的形成有三种不同方式:i)美拉德反应、多元醇途径和脂质过氧化。AGEs参与多种疾病发生发展的病理机制,如糖尿病及其并发症、视网膜病变或神经病变、神经障碍(例如帕金森病和阿尔茨海默病)、动脉粥样硬化、高血压以及多种类型的癌症。高血糖患者体内的AGE水平会升高,这可能是血液中循环的糖基化底物浓度过高所致。本综述总结了晚期糖基化终末产物的形成和命名,重点阐述了AGEs在糖尿病、神经障碍以及癌症和其他病症发生发展中的作用。特别关注了有毒AGEs的功能。此外,还讨论了显示糖化白蛋白和其他AGEs具有细胞毒性的研究。最后,强调了AGEs在诊断方面的相关性以及在治疗策略中的靶向作用。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/9e5e/7995243/01e4d25e6ae4/br-14-05-01422-g01.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/9e5e/7995243/ec5733482bf1/br-14-05-01422-g00.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/9e5e/7995243/01e4d25e6ae4/br-14-05-01422-g01.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/9e5e/7995243/ec5733482bf1/br-14-05-01422-g00.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/9e5e/7995243/01e4d25e6ae4/br-14-05-01422-g01.jpg

相似文献

1
Toxicity of advanced glycation end products (Review).晚期糖基化终末产物的毒性(综述)
Biomed Rep. 2021 May;14(5):46. doi: 10.3892/br.2021.1422. Epub 2021 Mar 18.
2
Inhibitors of Advanced Glycation End Product (AGE) Formation and Accumulation.抑制晚期糖基化终产物(AGE)的形成和积累。
Handb Exp Pharmacol. 2021;264:395-423. doi: 10.1007/164_2020_391.
3
Receptor for advanced glycation end products (RAGE)-mediated cytotoxicity of 3-hydroxypyridinium derivatives.晚期糖基化终末产物受体(RAGE)介导的3-羟基吡啶鎓衍生物的细胞毒性
Biosci Biotechnol Biochem. 2018 Feb;82(2):312-319. doi: 10.1080/09168451.2017.1422971. Epub 2018 Jan 10.
4
Naturally occurring inhibitors against the formation of advanced glycation end-products.天然存在的抑制剂,可抑制晚期糖基化终产物的形成。
Food Funct. 2011 Jun;2(6):289-301. doi: 10.1039/c1fo10034c. Epub 2011 Jun 15.
5
Pathologic role of dietary advanced glycation end products in cardiometabolic disorders, and therapeutic intervention.膳食晚期糖基化终产物在心脏代谢紊乱中的病理作用及治疗干预
Nutrition. 2016 Feb;32(2):157-65. doi: 10.1016/j.nut.2015.08.001. Epub 2015 Sep 1.
6
Advanced glycation end products and neurodegenerative diseases: mechanisms and perspective.糖基化终产物与神经退行性疾病:机制与展望。
J Neurol Sci. 2012 Jun 15;317(1-2):1-5. doi: 10.1016/j.jns.2012.02.018. Epub 2012 Mar 11.
7
Advanced Glycation End Products (AGEs), Glutathione and Breast Cancer: Factors, Mechanism and Therapeutic Interventions.晚期糖基化终产物(AGEs)、谷胱甘肽与乳腺癌:因素、机制与治疗干预。
Curr Drug Metab. 2019;20(1):65-71. doi: 10.2174/1389200219666180912104342.
8
Advanced glycation end-products produced systemically and by macrophages: A common contributor to inflammation and degenerative diseases.系统产生和巨噬细胞产生的晚期糖基化终产物:炎症和退行性疾病的共同诱因。
Pharmacol Ther. 2017 Sep;177:44-55. doi: 10.1016/j.pharmthera.2017.02.030. Epub 2017 Feb 13.
9
Advanced glycation end product ligands for the receptor for advanced glycation end products: biochemical characterization and formation kinetics.晚期糖基化终末产物受体的晚期糖基化终末产物配体:生化特性及形成动力学
Anal Biochem. 2004 Jan 1;324(1):68-78. doi: 10.1016/j.ab.2003.09.013.
10
Advanced glycation end products (AGEs) and cardiovascular dysfunction: focus on high molecular weight AGEs.高级糖基化终产物(AGEs)与心血管功能障碍:关注高分子量 AGEs。
Amino Acids. 2017 Sep;49(9):1535-1541. doi: 10.1007/s00726-017-2464-8. Epub 2017 Jul 14.

引用本文的文献

1
Global DNA Methylation in Poorly Controlled Type 2 Diabetes Mellitus: Association with Redox and Inflammatory Biomarkers.血糖控制不佳的2型糖尿病患者的全基因组DNA甲基化:与氧化还原和炎症生物标志物的关联
Int J Mol Sci. 2025 Jul 13;26(14):6716. doi: 10.3390/ijms26146716.
2
Correlation between serum advanced glycation end-products and their receptor-mediated oxidative stress and perinatal outcomes in gestational diabetes mellitus.妊娠期糖尿病患者血清晚期糖基化终产物及其受体介导的氧化应激与围产期结局的相关性
World J Diabetes. 2025 Jun 15;16(6):104177. doi: 10.4239/wjd.v16.i6.104177.
3
Endometriosis and Nutrition: Therapeutic Perspectives.

本文引用的文献

1
Resveratrol, curcumin and gallic acid attenuate glyoxal-induced damage to rat renal cells.白藜芦醇、姜黄素和没食子酸减轻乙二醛诱导的大鼠肾细胞损伤。
Toxicol Rep. 2020 Nov 23;7:1571-1577. doi: 10.1016/j.toxrep.2020.11.008. eCollection 2020.
2
Receptor for advanced glycation end-product rs1800624 polymorphism contributes to increase breast cancer risk: Evidence from a meta-analysis.晚期糖基化终产物受体rs1800624多态性增加乳腺癌风险:一项荟萃分析的证据
Medicine (Baltimore). 2020 Oct 30;99(44):e22775. doi: 10.1097/MD.0000000000022775.
3
Receptor for Advanced Glycation End Products Acts as a Fuel to Colorectal Cancer Development.
子宫内膜异位症与营养:治疗前景
J Clin Med. 2025 Jun 5;14(11):3987. doi: 10.3390/jcm14113987.
4
Mechanism and implications of advanced glycation end products (AGE) and its receptor RAGE axis as crucial mediators linking inflammation and obesity.晚期糖基化终末产物(AGE)及其受体RAGE轴作为连接炎症和肥胖的关键介质的机制及影响
Mol Biol Rep. 2025 Jun 5;52(1):556. doi: 10.1007/s11033-025-10632-x.
5
Synthetic and Natural Agents Targeting Advanced Glycation End-Products for Skin Anti-Aging: A Comprehensive Review of Experimental and Clinical Studies.针对晚期糖基化终产物的合成与天然皮肤抗衰剂:实验与临床研究综述
Antioxidants (Basel). 2025 Apr 20;14(4):498. doi: 10.3390/antiox14040498.
6
Flavonoids in Lotus Stamen Extract Inhibit High Glucose-Induced Intracellular Glycation in Fibroblasts by Upregulating the Expression of Glyoxalase 1 and Alleviating Oxidative Stress.莲须提取物中的类黄酮通过上调乙二醛酶1的表达和减轻氧化应激来抑制高糖诱导的成纤维细胞内糖基化。
Antioxidants (Basel). 2025 Mar 26;14(4):392. doi: 10.3390/antiox14040392.
7
The associations between skin advanced glycation end-products and Framingham cardiovascular risk in different age groups.不同年龄组中皮肤晚期糖基化终产物与弗雷明汉心血管风险之间的关联。
Front Cardiovasc Med. 2025 Apr 8;12:1491643. doi: 10.3389/fcvm.2025.1491643. eCollection 2025.
8
Unraveling the role of macrophages in diabetes: Impaired phagocytic function and therapeutic prospects.揭示巨噬细胞在糖尿病中的作用:吞噬功能受损及治疗前景。
Medicine (Baltimore). 2025 Feb 21;104(8):e41613. doi: 10.1097/MD.0000000000041613.
9
Perspective: Multiomics and Artificial Intelligence for Personalized Nutritional Management of Diabetes in Patients Undergoing Peritoneal Dialysis.视角:多组学与人工智能在腹膜透析患者糖尿病个性化营养管理中的应用
Adv Nutr. 2025 Mar;16(3):100378. doi: 10.1016/j.advnut.2025.100378. Epub 2025 Jan 20.
10
Effects of advanced glycation end products on stem cell.晚期糖基化终末产物对干细胞的影响。
Front Cell Dev Biol. 2024 Dec 24;12:1532614. doi: 10.3389/fcell.2024.1532614. eCollection 2024.
晚期糖基化终末产物受体是结直肠癌发展的助推器。
Front Oncol. 2020 Sep 29;10:552283. doi: 10.3389/fonc.2020.552283. eCollection 2020.
4
RAGE Up-Regulation Differently Affects Cell Proliferation and Migration in Pancreatic Cancer Cells.RAGE 上调对胰腺癌细胞增殖和迁移的影响不同。
Int J Mol Sci. 2020 Oct 19;21(20):7723. doi: 10.3390/ijms21207723.
5
Engineered cardiac tissues: a novel in vitro model to investigate the pathophysiology of mouse diabetic cardiomyopathy.工程化心脏组织:一种用于研究小鼠糖尿病心肌病病理生理学的新型体外模型。
Acta Pharmacol Sin. 2021 Jun;42(6):932-941. doi: 10.1038/s41401-020-00538-8. Epub 2020 Oct 9.
6
Metabolic transit of dietary advanced glycation end-products - the case of N-carboxymethyllysine.膳食晚期糖基化终产物的代谢转运——以 N-羧甲基赖氨酸为例。
Glycoconj J. 2021 Jun;38(3):311-317. doi: 10.1007/s10719-020-09950-y. Epub 2020 Sep 29.
7
Possible role of the receptor of advanced glycation end products (RAGE) in the clinical course of prostate neoplasia in patients with and without type 2 diabetes mellitus.晚期糖基化终产物受体(RAGE)在 2 型糖尿病和非 2 型糖尿病患者前列腺肿瘤临床病程中的可能作用。
Int J Clin Pract. 2021 Mar;75(3):e13723. doi: 10.1111/ijcp.13723. Epub 2020 Oct 13.
8
Dietary Advanced Glycation End-Products (dAGEs) Intake and Bone Health: A Cross-Sectional Analysis in the Rotterdam Study.饮食晚期糖基化终产物(dAGEs)摄入与骨骼健康:鹿特丹研究中的横断面分析。
Nutrients. 2020 Aug 8;12(8):2377. doi: 10.3390/nu12082377.
9
Impact of intracellular toxic advanced glycation end-products (TAGE) on murine myoblast cell death.细胞内毒性晚期糖基化终产物(TAGE)对小鼠成肌细胞死亡的影响。
Diabetol Metab Syndr. 2020 Jun 29;12:54. doi: 10.1186/s13098-020-00561-z. eCollection 2020.
10
Differential Effects of Dietary Patterns on Advanced Glycation end Products: A Randomized Crossover Study.膳食模式对晚期糖基化终产物的影响:一项随机交叉研究。
Nutrients. 2020 Jun 12;12(6):1767. doi: 10.3390/nu12061767.